{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:10:44Z","timestamp":1784553044260,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300759"],"award-info":[{"award-number":["81300759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00417-019-04314-1","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T18:29:19Z","timestamp":1556648959000},"page":"1443-1452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis"],"prefix":"10.1007","volume":"257","author":[{"given":"Anji","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tox.2009.01.008","volume":"258","author":"M Kernt","year":"2009","unstructured":"Kernt M, Kampik A (2009) Intracameral voriconazole: in vitro safety for human ocular cells. Toxicology 258:84\u201393. \n                    https:\/\/doi.org\/10.1016\/j.tox.2009.01.008","journal-title":"Toxicology"},{"key":"4314_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.18240\/ijo.2016.11.23","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu J, Zhang WS, Zhao J, Zhou HY (2016) Review of clinical and basic approaches of fungal keratitis. Int J Ophthalmol 9:1676\u20131683. \n                    https:\/\/doi.org\/10.18240\/ijo.2016.11.23","journal-title":"Int J Ophthalmol"},{"key":"4314_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaophthalmol.2013.1612","volume":"131","author":"NV Prajna","year":"2013","unstructured":"Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, Mascarenhas J, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM (2013) Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol 131:1088\u20131089. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.1612","journal-title":"JAMA Ophthalmol"},{"key":"4314_CR4","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/PL00007449","volume":"290","author":"ME Fini","year":"1998","unstructured":"Fini ME, Cook JR, Mohan R (1998) Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 290 Suppl:S12\u2013S23","journal-title":"Arch Dermatol Res"},{"key":"4314_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2147\/OPTH.S24532","volume":"5","author":"HM Anwar","year":"2011","unstructured":"Anwar HM, El-Danasoury AM, Hashem AN (2011) Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 5:1277\u20131280. \n                    https:\/\/doi.org\/10.2147\/OPTH.S24532","journal-title":"Clin Ophthalmol"},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1167\/iovs.07-1592","volume":"49","author":"SA Martins","year":"2008","unstructured":"Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin\/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402\u20133408. \n                    https:\/\/doi.org\/10.1167\/iovs.07-1592","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1089\/jop.2014.0044","volume":"30","author":"M Kimakura","year":"2014","unstructured":"Kimakura M, Usui T, Yokoo S, Nakagawa S, Yamagami S, Amano S (2014) Toxicity of topical antifungal agents to stratified human cultivated corneal epithelial sheets. J Ocul Pharmacol Ther 30:810\u2013814. \n                    https:\/\/doi.org\/10.1089\/jop.2014.0044","journal-title":"J Ocul Pharmacol Ther"},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1529\/biophysj.106.082388","volume":"91","author":"J Baier","year":"2006","unstructured":"Baier J, Maisch T, Maier M, Engel E, Landthaler M, Baumler W (2006) Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J 91:1452\u20131459. \n                    https:\/\/doi.org\/10.1529\/biophysj.106.082388","journal-title":"Biophys J"},{"key":"4314_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/meajo.MEAJO_305_16","volume":"24","author":"P Garg","year":"2017","unstructured":"Garg P, Das S, Roy A (2017) Collagen cross-linking for microbial keratitis. Middle East Afr J Ophthalmol 24:18\u201323. \n                    https:\/\/doi.org\/10.4103\/meajo.MEAJO_305_16","journal-title":"Middle East Afr J Ophthalmol"},{"key":"4314_CR10","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s12325-013-0065-9","volume":"30","author":"GD Kymionis","year":"2013","unstructured":"Kymionis GD, Mikropoulos DG, Portaliou DM, Voudouragkaki IC, Kozobolis VP, Konstas AG (2013) An overview of corneal collagen cross-linking (CXL). Adv Ther 30:858\u2013869. \n                    https:\/\/doi.org\/10.1007\/s12325-013-0065-9","journal-title":"Adv Ther"},{"key":"4314_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3980\/j.issn.2222-3959.2015.02.35","volume":"8","author":"A Alhayek","year":"2015","unstructured":"Alhayek A, Lu PR (2015) Corneal collagen crosslinking in keratoconus and other eye disease. Int J Ophthalmol 8:407\u2013418. \n                    https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.02.35","journal-title":"Int J Ophthalmol"},{"key":"4314_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ajo.2015.08.023","volume":"160","author":"DP O'Brart","year":"2015","unstructured":"O'Brart DP, Patel P, Lascaratos G, Wagh VK, Tam C, Lee J, O'Brart NA (2015) Corneal cross-linking to halt the progression of keratoconus and corneal ectasia: seven-year follow-up. Am J Ophthalmol 160:1154\u20131163. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2015.08.023","journal-title":"Am J Ophthalmol"},{"key":"4314_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3980\/j.issn.2222-3959.2012.02.15","volume":"5","author":"G Li","year":"2012","unstructured":"Li G, Fan ZJ, Peng XJ (2012) Corneal collagen crosslinking for corneal ectasia of post-LASIK: one-year results. Int J Ophthalmol 5:190\u2013195. \n                    https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2012.02.15","journal-title":"Int J Ophthalmol"},{"key":"4314_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/ICO.0000000000000004","volume":"33","author":"N Sharma","year":"2014","unstructured":"Sharma N, Roy S, Maharana PK, Sehra SV, Sinha R, Tandon R, Titiyal JS, Vajpayee RB (2014) Outcomes of corneal collagen crosslinking in pseudophakic bullous keratopathy. Cornea 33:243\u2013246. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000000004","journal-title":"Cornea"},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1167\/iovs.16-20110","volume":"57","author":"JM Alshehri","year":"2016","unstructured":"Alshehri JM, Caballero-Lima D, Hillarby MC, Shawcross SG, Brahma A, Carley F, Read ND, Radhakrishnan H (2016) Evaluation of corneal cross-linking for treatment of fungal keratitis: using confocal laser scanning microscopy on an ex vivo human corneal model. Invest Ophthalmol Vis Sci 57:6367\u20136373. \n                    https:\/\/doi.org\/10.1167\/iovs.16-20110","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 2","key":"4314_CR16","first-page":"211","volume":"78","author":"RP Goodrich","year":"2000","unstructured":"Goodrich RP (2000) The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 78(Suppl 2):211\u2013215","journal-title":"Vox Sang"},{"key":"4314_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/ICO.0b013e318169d698","volume":"27","author":"HP Iseli","year":"2008","unstructured":"Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A\/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27:590\u2013594. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e318169d698","journal-title":"Cornea"},{"key":"4314_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000456537","volume":"8","author":"V Igal","year":"2017","unstructured":"Igal V, Pikkel Igal YS, Pikkel YY (2017) Corneal cross-linking as a treatment for fungal keratitis associated with corneal melting. Case Rep Ophthalmol 8:148\u2013151. \n                    https:\/\/doi.org\/10.1159\/000456537","journal-title":"Case Rep Ophthalmol"},{"key":"4314_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/bjophthalmol-2014-304944","volume":"98","author":"R Shetty","year":"2014","unstructured":"Shetty R, Nagaraja H, Jayadev C, Shivanna Y, Kugar T (2014) Collagen crosslinking in the management of advanced non-resolving microbial keratitis. Br J Ophthalmol 98:1033\u20131035. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2014-304944","journal-title":"Br J Ophthalmol"},{"key":"4314_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/bjophthalmol-2012-302518","volume":"97","author":"Z Li","year":"2013","unstructured":"Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G (2013) Riboflavin\/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 97:669\u2013671. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302518","journal-title":"Br J Ophthalmol"},{"key":"4314_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1442-9071.1989.tb00536.x","volume":"17","author":"M Mohan","year":"1989","unstructured":"Mohan M, Panda A, Gupta SK (1989) Management of human keratomycosis with miconazole. Aust N Z J Ophthalmol 17:295\u2013297","journal-title":"Aust N Z J Ophthalmol"},{"key":"4314_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00417-007-0719-x","volume":"246","author":"W Shi","year":"2008","unstructured":"Shi W, Li S, Liu M, Jin H, Xie L (2008) Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol 246:581\u2013586. \n                    https:\/\/doi.org\/10.1007\/s00417-007-0719-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4314_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/ICO.0b013e318181cff7","volume":"28","author":"S Das","year":"2009","unstructured":"Das S, Samant M, Garg P, Vaddavalli PK, Vemuganti GK (2009) Role of confocal microscopy in deep fungal keratitis. Cornea 28:11\u201313. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e318181cff7","journal-title":"Cornea"},{"key":"4314_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","volume":"133","author":"S Campoy","year":"2017","unstructured":"Campoy S, Adrio JL (2017) Antifungals. Biochem Pharmacol 133:86\u201396. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2016.11.019","journal-title":"Biochem Pharmacol"},{"key":"4314_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.18240\/ijo.2018.02.07","volume":"11","author":"JY Wang","year":"2018","unstructured":"Wang JY, Wang DQ, Qi XL, Cheng J, Xie LX (2018) Modified ulcer debridement in the treatment of the superficial fungal infection of the cornea. Int J Ophthalmol 11:223\u2013229. \n                    https:\/\/doi.org\/10.18240\/ijo.2018.02.07","journal-title":"Int J Ophthalmol"},{"key":"4314_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/01.ico.0000248381.24519.0d","volume":"26","author":"L Xie","year":"2007","unstructured":"Xie L, Zhai H, Shi W (2007) Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea 26:158\u2013162. \n                    https:\/\/doi.org\/10.1097\/01.ico.0000248381.24519.0d","journal-title":"Cornea"},{"key":"4314_CR27","doi-asserted-by":"publisher","unstructured":"Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW, Jr. (2012) Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28: 706\u2013713 DOI \n                    https:\/\/doi.org\/10.3928\/1081597X-20120921-06","DOI":"10.3928\/1081597X-20120921-06"},{"key":"4314_CR28","doi-asserted-by":"publisher","unstructured":"Ozdemir HB, Kalkanci A, Bilgihan K, Gocun PU, Ogut B, Karakurt F, Erdogan M (2018) Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol. \n                    https:\/\/doi.org\/10.1111\/aos.13829","DOI":"10.1111\/aos.13829"},{"key":"4314_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.exer.2011.10.015","volume":"96","author":"K Kimura","year":"2012","unstructured":"Kimura K, Orita T, Nomi N, Fujitsu Y, Nishida T, Sonoda KH (2012) Identification of common secreted factors in human corneal fibroblasts exposed to LPS, poly(I:C), or zymosan. Exp Eye Res 96:157\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.exer.2011.10.015","journal-title":"Exp Eye Res"},{"key":"4314_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ceo.12399","volume":"43","author":"RB Vajpayee","year":"2015","unstructured":"Vajpayee RB, Shafi SN, Maharana PK, Sharma N, Jhanji V (2015) Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin Exp Ophthalmol 43:103\u2013107. \n                    https:\/\/doi.org\/10.1111\/ceo.12399","journal-title":"Clin Exp Ophthalmol"},{"key":"4314_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","volume":"35","author":"L Papaioannou","year":"2016","unstructured":"Papaioannou L, Miligkos M, Papathanassiou M (2016) Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea 35:62\u201371. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000000644","journal-title":"Cornea"},{"key":"4314_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/02713680490513182","volume":"29","author":"E Spoerl","year":"2004","unstructured":"Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35\u201340. \n                    https:\/\/doi.org\/10.1080\/02713680490513182","journal-title":"Curr Eye Res"},{"key":"4314_CR33","doi-asserted-by":"publisher","first-page":"406850","DOI":"10.1155\/2012\/406850","volume":"2012","author":"M Hovakimyan","year":"2012","unstructured":"Hovakimyan M, Guthoff RF, Stachs O (2012) Collagen cross-linking: current status and future directions. J Ophthalmol 2012:406850. \n                    https:\/\/doi.org\/10.1155\/2012\/406850","journal-title":"J Ophthalmol"},{"key":"4314_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000151247","volume":"222","author":"F Wang","year":"2008","unstructured":"Wang F (2008) UVA\/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica 222:369\u2013372. \n                    https:\/\/doi.org\/10.1159\/000151247","journal-title":"Ophthalmologica"},{"key":"4314_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1021\/tx000020e","volume":"13","author":"JP Pouget","year":"2000","unstructured":"Pouget JP, Douki T, Richard MJ, Cadet J (2000) DNA damage induced in cells by gamma and UVA radiation as measured by HPLC\/GC-MS and HPLC-EC and Comet assay. Chem Res Toxicol 13:541\u2013549","journal-title":"Chem Res Toxicol"},{"key":"4314_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1562\/2006-03-09-IR-840","volume":"83","author":"Y Hiraku","year":"2007","unstructured":"Hiraku Y, Ito K, Hirakawa K, Kawanishi S (2007) Photosensitized DNA damage and its protection via a novel mechanism. Photochem Photobiol 83:205\u2013212. \n                    https:\/\/doi.org\/10.1562\/2006-03-09-IR-840","journal-title":"Photochem Photobiol"},{"key":"4314_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/sj.eye.6700751","volume":"18","author":"G Wollensak","year":"2004","unstructured":"Wollensak G, Spoerl E, Reber F, Seiler T (2004) Keratocyte cytotoxicity of riboflavin\/UVA-treatment in vitro. Eye (Lond) 18:718\u2013722. \n                    https:\/\/doi.org\/10.1038\/sj.eye.6700751","journal-title":"Eye (Lond)"},{"key":"4314_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000074071","volume":"35","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Sporl E, Reber F, Pillunat L, Funk R (2003) Corneal endothelial cytotoxicity of riboflavin\/UVA treatment in vitro. Ophthalmic Res 35:324\u2013328 DOI 74071","journal-title":"Ophthalmic Res"},{"key":"4314_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICO.0b013e3180334f78","volume":"26","author":"E Spoerl","year":"2007","unstructured":"Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26:385\u2013389. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e3180334f78","journal-title":"Cornea"},{"key":"4314_CR40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/ICO.0b013e318030df5a","volume":"26","author":"C Mazzotta","year":"2007","unstructured":"Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, Caporossi A (2007) Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea 26:390\u2013397. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e318030df5a","journal-title":"Cornea"},{"key":"4314_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/ICO.0b013e31820143d1","volume":"30","author":"F Hafezi","year":"2011","unstructured":"Hafezi F (2011) Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea. Cornea 30:917\u2013919. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e31820143d1","journal-title":"Cornea"},{"key":"4314_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jtos.2013.01.003","volume":"11","author":"F Raiskup","year":"2013","unstructured":"Raiskup F, Spoerl E (2013) Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf 11:93\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.jtos.2013.01.003","journal-title":"Ocul Surf"},{"key":"4314_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/bjo.82.8.919","volume":"82","author":"MR Rahman","year":"1998","unstructured":"Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC (1998) Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol 82:919\u2013925","journal-title":"Br J Ophthalmol"},{"key":"4314_CR44","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/archopht.1981.03930011081019","volume":"99","author":"CS Foster","year":"1981","unstructured":"Foster CS, Lass JH, Moran-Wallace K, Giovanoni R (1981) Ocular toxicity of topical antifungal agents. Arch Ophthalmol 99:1081\u20131084","journal-title":"Arch Ophthalmol"},{"key":"4314_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/bjo.79.8.777","volume":"79","author":"BD Allan","year":"1995","unstructured":"Allan BD, Dart JK (1995) Strategies for the management of microbial keratitis. Br J Ophthalmol 79:777\u2013786","journal-title":"Br J Ophthalmol"},{"key":"4314_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/APO.0b013e3182993f4b","volume":"2","author":"P Zloty","year":"2013","unstructured":"Zloty P, Villavicencio O, Belin MW (2013) Aggressive debridement improves outcome of fungal keratitis. Asia Pac J Ophthalmol (Phila) 2:217\u2013220. \n                    https:\/\/doi.org\/10.1097\/APO.0b013e3182993f4b","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"4314_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.survophthal.2013.03.004","volume":"59","author":"LA McGrath","year":"2014","unstructured":"McGrath LA, Lee GA (2014) Techniques, indications and complications of corneal debridement. Surv Ophthalmol 59:47\u201363. \n                    https:\/\/doi.org\/10.1016\/j.survophthal.2013.03.004","journal-title":"Surv Ophthalmol"},{"key":"4314_CR48","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.jcrs.2014.09.001","volume":"40","author":"E Chan","year":"2014","unstructured":"Chan E, Snibson GR, Sullivan L (2014) Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation. J Cataract Refract Surg 40:1919\u20131925. \n                    https:\/\/doi.org\/10.1016\/j.jcrs.2014.09.001","journal-title":"J Cataract Refract Surg"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04314-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T23:14:04Z","timestamp":1588115644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04314-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}